moderna emergency use authorization

News

FDA, COVID and Moderna

Moderna gets full US approval for COVID vaccine in children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

· 1d

Moderna COVID vaccine gets FDA green light for kids 6 months to 11 years

STAT · 1d

FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility

StockStory.org on MSN2d

Why Moderna (MRNA) Stock Is Up Today

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...

Yahoo Finance2y

Moderna Receives FDA Authorization for Emergency Use of Omicron ...

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has received emergency use authorization (EUA) from the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

FDA, COVID and Moderna

Trending now